Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 11)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Neurogen Corporation Financial and Strategic Analysis Review 19 $300 View Abstract
31-Dec-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Neurogen Corporation 41 $65 View Abstract
24-Dec-09 RiskMetrics Group N/A ISS Report on Neurogen Corp. 11 $135 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for NRGN 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Health Care Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. 65 $40 View Abstract
28-Mar-09 Standard & Poor's Quantitative Report N/A Neurogen Corp 6 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NEUROGEN CORP (NRGN=US) 12-months forecast 1 $15 View Abstract
Next 1

Independent Reports (Showing 1 to 10 of 11)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Neurogen Corporation Financial and Strategic Analysis Review 19 $300 View Abstract
31-Dec-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Neurogen Corporation 41 $65 View Abstract
24-Dec-09 RiskMetrics Group N/A ISS Report on Neurogen Corp. 11 $135 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for NRGN 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Health Care Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. 65 $40 View Abstract
28-Mar-09 Standard & Poor's Quantitative Report N/A Neurogen Corp 6 $25 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NEUROGEN CORP (NRGN=US) 12-months forecast 1 $15 View Abstract
Next 1

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.